TipRanks
Quantum Biopharma (QNTM)
NASDAQ:QNTM
US Market
QNTM
Quantum Biopharma
RESEARCH TOOLSreports
Want to see QNTM full AI Analyst Report?

Quantum Biopharma (QNTM) Income Statement

700 Followers

Quantum Biopharma Income Statement

Last quarter (Q2 2026), Quantum Biopharma's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q2, Quantum Biopharma's net income was C$-3.17M. See Quantum Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Mar 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 15.30M$ 16.14M$ 23.79M$ 27.43M$ 33.74M
Depreciation and Amortization
$ 545.78K$ 490.57K$ 2.51M$ 4.53M$ 4.05M
EBITDA
$ -25.79M$ -14.38M$ -15.72M$ -22.12M$ -29.82M
Operating Income
$ -15.30M$ -16.14M$ -23.79M$ -27.43M$ -33.74M
Other Income/Expenses
$ -11.65M$ 1.22M$ 5.56M$ 725.95K$ -194.30K
Pretax Income
$ -26.96M$ -14.92M$ -18.23M$ -26.70M$ -33.94M
Net Income
$ -26.18M$ -14.20M$ -17.90M$ -23.61M$ -35.29M
Per Share Metrics
Basic EPS
$ -8.11$ -12.49$ -29.39$ -39.62$ -65.63
Diluted EPS
$ -8.11$ -12.49$ -29.39$ -39.62$ -65.63
Weighted Average Shares Outstanding
 3.29M 1.14M 609.06K 595.88K 537.62K
Weighted Average Shares Outstanding (Diluted)
 3.29M 1.14M 609.06K 595.88K 537.62K

Quantum Biopharma Earnings and Revenue History